Titre:
  • Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer
Auteur:Van Laethem, Jean-Luc; Melichar, Bohuslav; Cascinu, Stefano; Saramak, Piotr; Michl, Patrick; Van Brummelen, David; Zaniboni, Alberto; Schmiegel, Wollf; Dueland, Svein; Giurescu, Marius; Garosi, Vittorio V.L.; Riess, Hanno; Roth, Katrin; Schulz, Anke; Seidel, Henrik; Rajagopalan, Prabhu; Teufel, Michael; Childs, Barrett B.H.; Jassem, Jacek; Haas, Michael; Martens, Uwe U.M.; Weekes, Colin; Peeters, Michel; Ross, Paul; Bridgewater, John
Informations sur la publication:Targeted Oncology, 12, 1, page (97-109)
Statut de publication:Publié, 2017-02
Sujet CREF:Cancérologie
Pharmacologie
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1776-2596
info:doi/10.1007/s11523-016-0469-y
info:scp/85006129598